Edition:
United Kingdom

Natco Pharma Ltd (NATP.NS)

NATP.NS on National Stock Exchange of India

1,008.30INR
4:47am GMT
Change (% chg)

Rs46.45 (+4.83%)
Prev Close
Rs961.85
Open
Rs970.00
Day's High
Rs1,014.00
Day's Low
Rs966.05
Volume
432,328
Avg. Vol
417,532
52-wk High
Rs1,090.00
52-wk Low
Rs555.05

Chart for

About

Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The... (more)

Overall

Beta: 0.37
Market Cap(Mil.): Rs173,105.09
Shares Outstanding(Mil.): 174.31
Dividend: 1.25
Yield (%): 0.73

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Natco Pharma Approved Allocation Of 10 Mln Shares At 915 Rupees/Share Upon Closure Of QIP

* NATCO PHARMA - APPROVED ALLOCATION OF 10 MILLION SHARES AT ISSUE PRICE OF 915 RUPEES PER SHARE UPON CLOSURE OF QIP Source text: http://bit.ly/2zbT0ZA Further company coverage:

8:09am GMT

BRIEF-Natco Pharma Approves QIP Floor Price Of 937.63 Rupees/Shr

* SAYS APPROVED QIP FLOOR PRICE OF 937.63 RUPEES PER SHARE Source text: http://bit.ly/2AJA9El Further company coverage:

11 Dec 2017

BRIEF-India's Natco Pharma Sept-qtr consol profit up about 28 pct

* Sept quarter consol net profit 848 million rupees versus profit of 665 million rupees last year

02 Nov 2017

BRIEF-Natco Pharma's marketing partner Mylan launches generic glatiramer acetate in U.S.

* Says marketing partner mylan launches generic glatiramer acetate in U.S. Market Source text - http://bit.ly/2xUtxo0 Further company coverage:

05 Oct 2017

BRIEF-Natco Pharma gets shareholders' nod for re-appointing V.C. Nannapaneni as chairman, MD

* Gets shareholders' nod for re-appointment of V.C. Nannapaneni as chairman, MD Source text - http://bit.ly/2wuXVkS Further company coverage:

03 Oct 2017

BRIEF-Natco Pharma gets shareholders' nod for reappointment of V C Nannapaneni as chairman, MD

* Gets shareholders' nod for reappointment of V C Nannapaneni as chairman, MD

29 Sep 2017

BRIEF-Natco Pharma says co, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

* Says Natco, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

14 Aug 2017

BRIEF-India's Natco Pharma June-qtr consol profit surges

* June quarter consol profit 940 million rupees versus profit of 477 million rupees last year

07 Aug 2017

BRIEF-Natco Pharma gets final ANDA approval for azacitidine for injection

* Says Natco receives final approval for generic azacitidine for injection for USA market

27 Jun 2017

Earnings vs. Estimates